Actively Recruiting
Long-term Study of Survival in Patients Treated for Malignant Tumors at Fudan University Shanghai Cancer Center
Led by Fudan University · Updated on 2021-08-09
500000
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
This research focuses on patients who have undergone anti-tumor treatments while hospitalized for malignant tumors. It aims to observe long-term outcomes such as overall survival and disease-free survival in a real-world setting, using data from a hospital-based cancer registry in China. The study explores factors influencing cancer survival from both clinical and socio-economic perspectives. Participants include patients treated with surgery, radiotherapy, chemotherapy, or immunotherapy during their hospital stay. The study collects data continuously at a single center, grouping patients by cancer site, and follows them over time to gather survival information. Follow-up involves reviewing medical records, telephone interviews, and linking data to provincial death certificate registries. Researchers measure overall survival and disease-free survival over a 15-year period to provide valuable long-term data on cancer prognosis. The study began in 2008 and will continue through 2041.
CONDITIONS
Brief Title
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
Research Team
Y
Ying Zheng, Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
